Background： Gastrointestinal dysfunction plays a critical role in the prognosis of critically ill patients. Previous studies showed rhubarb, a traditional Chinese herb, can protect the intestinal barrier function, pr...Background： Gastrointestinal dysfunction plays a critical role in the prognosis of critically ill patients. Previous studies showed rhubarb, a traditional Chinese herb, can protect the intestinal barrier function, prevent intestinal bacterial translocation, and promote gastrointestinal peristalsis, but the clinical studies are less. The aim of this study was to evaluate the effects of rhubarb on gastrointestinal dysfunction in critically ill patients. Methods： From June 2015 to May 2017, a total of 368 critically ill patients with Grade I III acute gastrointestinal injury （AGI） were enrolled in this study. Patients were divided into two groups according to the exposure factors （whether the patients received rhubarb treatment）： the rhubarb group and the usual treatment group. Clinical data were collected within the first 24 h of the Intensive Care Unit （ICU） admission and 7 days after treatment. Survival data on day 28 after ICU admission and the durations oflCU and total hospitalization were also collected. Propensity score matching （PSM） was conducted to reduce confounding bias between the groups. The logistic regression was conducted to screen the influence factors. Results： The eligible patients were divided into rhubarb group （n = 219, 59.5%） and usual treatment group （n = 149, 40.5%）. Betbre PSM, the remission rate of feeding intolerance in rhubarb group and usual treatment group were 59.8% and 39.6%, respectively. After PSM, the remission rate of feeding intolerance in rhubarb group and usual treatment group was 77.9% and 30.9%, respectively. The remission rates of feeding intolerance in rhubarb group were significantly higher than those in the usual treatment group （all P 〈 0.05）. Compared with the usual treatment group, the rhubarb group had a higher rate of AGI improvement, lower level of C-reactive protein, shorter stay in ICU before and after PSM （P 〈 0.05）. There was no significant difference in 28-day mortality between rhubarb and usual treatment groups before and after PSM （48 vs. 33, P 0.959; and 16 vs. 21, P = 0.335）. The logistic regression analysis showed that the single factor, whether receiving rhubarb therapy, affected the proportion of patients whose enteral nutrition needs ≥83.7 kJ·kg^-1d^-1 after 7 days of treatment （odds ratio： 7.908, 95% confidence interval： 3.661-17.083, P 〈 0.001）. No serious adverse effects were found in two groups. Conclusions： The rhubarb might significantly improve feeding tolerance and relieve gastrointestinal dysfunction in critically ill patients, without serious adverse reactions. It provided proof for the treatment of gastrointestinal dysfunction with rhubarb during clinical practice.展开更多
文摘Background： Gastrointestinal dysfunction plays a critical role in the prognosis of critically ill patients. Previous studies showed rhubarb, a traditional Chinese herb, can protect the intestinal barrier function, prevent intestinal bacterial translocation, and promote gastrointestinal peristalsis, but the clinical studies are less. The aim of this study was to evaluate the effects of rhubarb on gastrointestinal dysfunction in critically ill patients. Methods： From June 2015 to May 2017, a total of 368 critically ill patients with Grade I III acute gastrointestinal injury （AGI） were enrolled in this study. Patients were divided into two groups according to the exposure factors （whether the patients received rhubarb treatment）： the rhubarb group and the usual treatment group. Clinical data were collected within the first 24 h of the Intensive Care Unit （ICU） admission and 7 days after treatment. Survival data on day 28 after ICU admission and the durations oflCU and total hospitalization were also collected. Propensity score matching （PSM） was conducted to reduce confounding bias between the groups. The logistic regression was conducted to screen the influence factors. Results： The eligible patients were divided into rhubarb group （n = 219, 59.5%） and usual treatment group （n = 149, 40.5%）. Betbre PSM, the remission rate of feeding intolerance in rhubarb group and usual treatment group were 59.8% and 39.6%, respectively. After PSM, the remission rate of feeding intolerance in rhubarb group and usual treatment group was 77.9% and 30.9%, respectively. The remission rates of feeding intolerance in rhubarb group were significantly higher than those in the usual treatment group （all P 〈 0.05）. Compared with the usual treatment group, the rhubarb group had a higher rate of AGI improvement, lower level of C-reactive protein, shorter stay in ICU before and after PSM （P 〈 0.05）. There was no significant difference in 28-day mortality between rhubarb and usual treatment groups before and after PSM （48 vs. 33, P 0.959; and 16 vs. 21, P = 0.335）. The logistic regression analysis showed that the single factor, whether receiving rhubarb therapy, affected the proportion of patients whose enteral nutrition needs ≥83.7 kJ·kg^-1d^-1 after 7 days of treatment （odds ratio： 7.908, 95% confidence interval： 3.661-17.083, P 〈 0.001）. No serious adverse effects were found in two groups. Conclusions： The rhubarb might significantly improve feeding tolerance and relieve gastrointestinal dysfunction in critically ill patients, without serious adverse reactions. It provided proof for the treatment of gastrointestinal dysfunction with rhubarb during clinical practice.
